DK0960336T3 - Peptidreagens til påvisning af humant cytomelagovirus (CMV) - Google Patents

Peptidreagens til påvisning af humant cytomelagovirus (CMV)

Info

Publication number
DK0960336T3
DK0960336T3 DK97932819T DK97932819T DK0960336T3 DK 0960336 T3 DK0960336 T3 DK 0960336T3 DK 97932819 T DK97932819 T DK 97932819T DK 97932819 T DK97932819 T DK 97932819T DK 0960336 T3 DK0960336 T3 DK 0960336T3
Authority
DK
Denmark
Prior art keywords
cmv
detection
antibodies
human
cytomelagovirus
Prior art date
Application number
DK97932819T
Other languages
English (en)
Inventor
De Crommert Johannes Marti Van
Jaap Michiel Middeldorp
Original Assignee
Organon Teknika Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Teknika Bv filed Critical Organon Teknika Bv
Application granted granted Critical
Publication of DK0960336T3 publication Critical patent/DK0960336T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK97932819T 1996-07-12 1997-07-09 Peptidreagens til påvisning af humant cytomelagovirus (CMV) DK0960336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201972 1996-07-12
PCT/EP1997/003717 WO1998002746A1 (en) 1996-07-12 1997-07-09 Peptide reagent for the detection of human cytomegalovirus (cmv)

Publications (1)

Publication Number Publication Date
DK0960336T3 true DK0960336T3 (da) 2003-02-10

Family

ID=8224180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97932819T DK0960336T3 (da) 1996-07-12 1997-07-09 Peptidreagens til påvisning af humant cytomelagovirus (CMV)

Country Status (12)

Country Link
US (1) US6936251B2 (da)
EP (1) EP0960336B1 (da)
JP (1) JP4218985B2 (da)
KR (1) KR100624517B1 (da)
AT (1) ATE225942T1 (da)
AU (1) AU735981B2 (da)
DE (1) DE69716305T2 (da)
DK (1) DK0960336T3 (da)
ES (1) ES2187796T3 (da)
ID (1) ID19063A (da)
WO (1) WO1998002746A1 (da)
ZA (1) ZA976196B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919121B4 (de) * 1999-04-27 2012-08-02 F. Hoffmann-La Roche Ag Multimeres CMV-Antigen
AU2002214624A1 (en) * 2000-10-20 2002-05-06 City Of Hope Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150
AUPR593101A0 (en) * 2001-06-26 2001-07-19 Council Of The Queensland Institute Of Medical Research, The Cytomegalovirus t cell epitopes
ITMI20012160A1 (it) * 2001-10-18 2003-04-18 Edoardo Marchisio Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
JP2010517544A (ja) * 2007-02-07 2010-05-27 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ ヒトサイトメガロウイルス（ｈｃｍｖ）の組換え抗原
SG10201608381SA (en) 2008-07-16 2016-11-29 Inst Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
US20120093848A1 (en) * 2009-06-26 2012-04-19 Vectorite Biomedica Inc. Immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
JP5712513B2 (ja) * 2010-07-07 2015-05-07 富士レビオ株式会社 ヒトサイトメガロウイルス感染の検出方法
NZ591514A (en) * 2011-03-03 2013-11-29 Kode Biotech Ltd Assay method
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白Ｂ（ｇＢ）多肽

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248909B1 (en) * 1985-12-06 1994-08-17 Teijin Limited Anticytomegaloviral human monoclonal antibody and process for its preparation
CA1335429C (en) * 1986-03-07 1995-05-02 Geoffrey L. Smith Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
ATE132533T1 (de) * 1988-02-24 1996-01-15 Behringwerke Ag Strukturelles phosphoprotein (pp28) des menschlichen cytomegalovirus (hcmv), seine herstellung und verwendung
GB9014652D0 (en) * 1990-07-02 1990-08-22 Wellcome Found Antigen
US5744298A (en) * 1991-08-29 1998-04-28 Behringwerke Aktiengesellschaft DNA sequences which encode immunoreactive HCMV-specific peptides
DE4128684A1 (de) 1991-08-29 1993-03-04 Behringwerke Ag Hcmv-spezifische peptide, mittel dazu und ihre verwendung
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
EP0702083A3 (de) * 1994-07-26 1997-01-15 Biotest Ag Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien
DE4426453C1 (de) * 1994-07-26 1995-11-02 Biotest Ag Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits

Also Published As

Publication number Publication date
AU735981B2 (en) 2001-07-19
EP0960336A1 (en) 1999-12-01
US20030119039A1 (en) 2003-06-26
KR20000023701A (ko) 2000-04-25
AU3623197A (en) 1998-02-09
EP0960336B1 (en) 2002-10-09
US6936251B2 (en) 2005-08-30
ID19063A (id) 1998-06-11
JP4218985B2 (ja) 2009-02-04
DE69716305T2 (de) 2003-06-26
ES2187796T3 (es) 2003-06-16
JP2000514300A (ja) 2000-10-31
ATE225942T1 (de) 2002-10-15
DE69716305D1 (de) 2002-11-14
WO1998002746A1 (en) 1998-01-22
ZA976196B (en) 1998-09-01
KR100624517B1 (ko) 2006-09-18

Similar Documents

Publication Publication Date Title
DK0960336T3 (da) Peptidreagens til påvisning af humant cytomelagovirus (CMV)
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
HUP0103650A2 (hu) Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására
SE9500023D0 (sv) Method of detecting cancer
ATE258310T1 (de) Testverfahren für collagenpeptid
EP0696640A3 (de) Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
DK1336109T3 (da) Kit og fremgangsmåde til at påvise proteinet EMS-1
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
NO962084L (no) DNA sekvens som koder for en BMP reseptor
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
ATE288589T1 (de) Verfahren zur analyse von proteinen
DK1145012T3 (da) Fremgangsmåder og kits til sekventering af polypeptider
DK0607425T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
CA2259967A1 (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
NO983984L (no) Disintegrin-metalloprotease samt anvendelse derav
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
AR013326A1 (es) POLIPEPTIDO AISLADO, MOLECULA DE ADN, VECTOR DE EXPRESION RECOMBINANTE, CELULA HUESPED, METODO PARa DETECTAR LA INFECCION DE M.TUBERCULOSIS EN UNAMUESTRA BIOLOGICA, EQUIPO PARA DIAGNOSTICO, ANTICUERPO MONOCLONAL, Y ANTICUERPO POLICLONAL, PROTEINAS DE FUSION
NO994056L (no) Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav